After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Neuronetics Inc. (STIM) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.05, or 1.33%, to $3.80. The Neuronetics Inc. has recorded 3,879 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Stocks Info
Neuronetics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $3.75 and fluctuated between $4.2500 as its day high and $3.6200 as its day low. The current market capitalization of Neuronetics Inc. is $101.10M. A total of 1.03 million shares were traded on the day, compared to an average of 216.41K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, STIM has seen 3 BUY and 22 SELL insider trades, representing the acquisition of 195,783 and the disposition of 590,377 shares. Over the last 12 months, there were 47 BUYs and 27 SELLs from insiders. Insiders purchased 1,371,115 shares during that period but sold 681,569.
In the most recent transaction, MACAN WILLIAM ANDREW sold 11,044 shares of STIM for 5.91 per share on Feb 16. After the transaction, the EVP, GC, CCO and CS now owns 400,539 company shares. In a previous transaction on Feb 15, Furlong Stephen sold 13,148 shares at 5.90 per share. STIM shares that CFO owns now total 442,134.
Among the insiders who sold shares, MACAN WILLIAM ANDREW disposed of 11,974 shares on Feb 15 at a per-share price of $5.90. This resulted in the EVP, GC, CCO and CS holding 411,583 shares of STIM after the transaction. In another insider transaction, Sullivan Keith J sold 13,647 shares at $5.58 per share on Feb 14. Company shares held by the President and CEO now total 1,197,198.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for STIM in the last 3 months, the mean price target is $8.67 with high estimates of $12.00 and low estimates of $7.00. In terms of 52-week highs and lows, STIM has a high of $6.95 and a low of $1.98.
As of this writing, STIM has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.43. The company reported an EPS of -$0.39 in the last quarter, which was 4.90% higher than expectations of -$0.41.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STIM is Buy with a score of 4.00. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
